Moderna Inc and Swiss contract drugmaker Lonza Group AG said on Friday they would accelerate the manufacturing of the U.S. drug developer’s potential coronavirus vaccine.
Click here for original story, Moderna, Switzerland’s Lonza strike deal on potential COVID-19 vaccine
Source: Reuters Science News